ArticleJournal of pharmacy & bioallied sciences2025
Effectiveness of Nano-hydroxyapatite-coated Implants against Peri-implantitis Bacteria.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preventing peri-implantitis with Ag-Est816 nanocomposite: modified rat model and preventive assessment.Frontiers in oral health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Peri-implantitis, a prevalent complication of dental implants, is characterized by inflammation and bone loss caused by bacterial colonization around the implant surface. Nano-hydroxyapatite (nHA)-coated implants have shown promise in enhancing osseointegration and providing antibacterial properties. Materials and Methods: A total of 40 dental implants were divided into two groups: Group A ( Results: Group A demonstrated a significant reduction in bacterial adhesion and biofilm formation compared to Group B ( Conclusion: Nano-hydroxyapatite-coated implants significantly inhibit the growth of peri-implantitis-associated bacteria and reduce biofilm formation, making them a promising alternative for reducing peri-implantitis risk. Further clinical studies are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.